Further processing options
CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells
Saved in:
Journal Title: | Journal for ImmunoTherapy of Cancer |
---|---|
Authors and Corporations: | , , , , , , , , , , , , , |
In: | Journal for ImmunoTherapy of Cancer, 3, 2015, S2 |
Type of Resource: | E-Article |
Language: | English |
published: |
BMJ
|
Subjects: |